LY96 and infection: Understanding these pathways, their interconnections, and the crosstalk between them and TLR4/MD‐2 is essential for guiding the development of pharmacologically active molecules that could specifically modulate the inflammatory response, paving the way to new strategies for combating immune‐mediated diseases and resistant infections.